6 February 2024
2023 : A year of delivery Financial summary Fourth Third Fourth quarter quarter quarter Year Year $…
· Application supported by positive results of a phase III trial showing immune response and acceptable tolerability profile in this population · Adults aged 50 and…
GSK’s regulatory application for Shingrix for the prevention of shingles in at-risk adults aged 18 and over accepted for review by China National Medical Products Administration…
DREAMM-7 phase III trial shows Blenrep combination nearly tripled median progression-free survival versus standard of care combination in patients with relapsed/refractory multiple myeloma · 59% reduction in…
5 February 2024
5 February 2024 Sustained revenue growth in Europe & Africa Margherita Della Valle, Vodafone Group Chief Executive, commented: “We maintained good service…
2 February 2024
SHELL PLC4th QUARTER 2023 AND FULL YEAR UNAUDITED RESULTS …
1 February 2024
Trading update for the nine months to 31 December 2023 BT Group plc – 1 February 2024 Allison Kirkby, Chief Executive, commenting on the results, said“BT…
1 February 2024 A.G. BARR p.l.c. (“A.G. BARR” or the “Group”) A.G. BARR is a branded multi-beverage business with a portfolio of market-leading UK…